These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7750288

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 24. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months.
    Dibbelt L, Knuppen R, Jütting G, Heimann S, Klipping CO, Parikka-Olexik H.
    Contraception; 1991 Jan; 43(1):1-21. PubMed ID: 1825969
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE, Mesure R.
    Br J Clin Pharmacol; 1995 Jan; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [Abstract] [Full Text] [Related]

  • 27. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
    Hammond GL, Bocchinfuso WP, Orava M, Smith CL, van den Ende A, van Enk A.
    Contraception; 1994 Oct; 50(4):301-18. PubMed ID: 7813219
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Dec; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
    Hammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK.
    Contraception; 2003 Feb; 67(2):93-9. PubMed ID: 12586319
    [Abstract] [Full Text] [Related]

  • 34. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
    Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E.
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):458-67. PubMed ID: 21942708
    [Abstract] [Full Text] [Related]

  • 35. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V, Johannisson E, Landgren BM, Cekan SZ, Diczfalusy E.
    Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
    [Abstract] [Full Text] [Related]

  • 36. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
    el-Raghy I, Back DJ, Makeram M, Salem H, Osman F, Fathalla M, Orme ML.
    Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Estimating systemic exposure to levonorgestrel from an oral contraceptive.
    Basaraba CN, Westhoff CL, Pike MC, Nandakumar R, Cremers S.
    Contraception; 2017 Apr; 95(4):398-404. PubMed ID: 28041990
    [Abstract] [Full Text] [Related]

  • 40. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA, Stanczyk FZ.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.